Follow
Chandra Kumar Elechalawar, Ph.D.
Chandra Kumar Elechalawar, Ph.D.
Postdoctoral Research Associate
Verified email at ouhsc.edu
Title
Cited by
Cited by
Year
Polyketide quinones are alternate intermediate electron carriers during mycobacterial respiration in oxygen-deficient niches
A Anand, P Verma, AK Singh, S Kaushik, R Pandey, C Shi, H Kaur, ...
Molecular cell 60 (4), 637-650, 2015
482015
Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro
Y Zhang, X Xiong, Y Huai, A Dey, MN Hossen, RV Roy, CK Elechalawar, ...
Bioconjugate chemistry 30 (6), 1724-1733, 2019
452019
Analysing the nanoparticle-protein corona for potential molecular target identification
CK Elechalawar, MN Hossen, L McNally, R Bhattacharya, P Mukherjee
Journal of controlled release 322, 122-136, 2020
402020
Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells
Y Zhang, CK Elechalawar, MN Hossen, ER Francek, A Dey, S Wilhelm, ...
Bioactive materials 6 (2), 326-332, 2021
372021
Revealing macropinocytosis using nanoparticles
N Means, CK Elechalawar, WR Chen, R Bhattacharya, P Mukherjee
Molecular aspects of medicine 83, 100993, 2022
332022
Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere–cationic folate nanoconjugate
CK Elechalawar, D Bhattacharya, MT Ahmed, H Gora, K Sridharan, ...
Nanoscale Advances 1 (9), 3555-3567, 2019
292019
Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression
CK Elechalawar, K Sridharan, A Pal, MT Ahmed, M Yousuf, SS Adhikari, ...
Biomaterials science 5 (9), 1898-1909, 2017
252017
Targeting pancreatic cancer cells and stellate cells using designer nanotherapeutics in vitro
CK Elechalawar, MN Hossen, P Shankarappa, CJ Peer, WD Figg, ...
International Journal of Nanomedicine, 991-1003, 2020
202020
Gold nanoparticles disrupt the IGFBP2/mTOR/PTEN axis to inhibit ovarian cancer growth
MN Hossen, L Wang, SKD Dwivedi, Y Zhang, G Rao, CK Elechalwar, ...
Advanced Science 9 (31), 2200491, 2022
72022
Experimental conditions influence the formation and composition of the corona around gold nanoparticles
MN Hossen, CK Elechalawar, V Sjoelund, K Moore, R Mannel, ...
Cancer Nanotechnology 12, 1-19, 2021
62021
Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressiveness
Y Zhang, CK Elechalawar, W Yang, AN Frickenstein, S Asfa, KM Fung, ...
Materials Today 56, 79-95, 2022
52022
Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation
CK Elechalawar, G Rao, SK Gulla, MM Patel, A Frickenstein, N Means, ...
ACS nano 17 (10), 9326-9337, 2023
22023
Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer
CK Elechalawar, SK Gulla, RV Roy, N Means, Y Zhang, S Asifa, ...
Cancer Letters, 216810, 2024
2024
Carbon nanosphere-folate receptor targeting ligand conjugate, complex and composition and method of preparation thereof.
TKK ,Rajkumar Banerjee, Muthusamy Eswaramoorthy, Chandra Kumar Elechelawar ...
IN Patent App. 201841009113,, 2018
2018
Folate Receptor Targeted Liposomal and Carbon Nanosphere-Based Drug Delivery Systems for Combating Melanoma and Glioblastoma
CK Elechalawar
CSIR-Indian Institute of Chemical Technology, Hyderabad, 2017
2017
Disrupting Pancreatic Cancer Cell–Stellate Cell Crosstalk Using a Targeted Drug Delivery System
CK Elechalawar, SK Gulla, R Roy, N Means, Y Zhang, S Asif, ...
Available at SSRN 4613406, 0
The system can't perform the operation now. Try again later.
Articles 1–16